-+ 0.00%
-+ 0.00%
-+ 0.00%

Monopar Therapeutics Director Kim R. Tsuchimoto Reports Sale of $290,061.75 in Common Shares

PUBT·11/05/2026 01:15:56
Listen to the news
Monopar Therapeutics Director Kim R. Tsuchimoto Reports Sale of $290,061.75 in Common Shares
  • Monopar Therapeutics director Kim R. Tsuchimoto sold 4,090 common shares on November 2 and 4, 2026.
  • Reported sale prices ranged from $70.1 to $72.21 per share.
  • Tsuchimoto exercised stock options for 2,055 shares at $30 per share and 2,035 shares at $14 per share.
  • Following the transactions, she held no common shares directly; indirect common stock ownership totaled 11,486 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monopar Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-035039), on November 04, 2026, and is solely responsible for the information contained therein.